Navigation Links
Delcath Signs First Partner Agreement in Asia
Date:2/9/2010

NEW YORK, Feb. 9 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. ( DCTH), a medical technology company testing its proprietary treatment system for primary and metastatic cancers to the liver, announced today the signing of its first research, distribution, sales and marketing agreement for its Percutaneous Hepatic Perfusion (PHP) System  (the Delcath PHP System™).  The agreement grants Chi-Fu Trading Co., Ltd. the exclusive right to market and sell the Delcath PHP System in Taiwan for hepatic malignancies and infectious disease upon Taiwan Food and Drug Administration (TFDA) approval, and any other approved use, with a conditional option for Singapore. 

Under terms of the agreement, Chi-Fu will fund and manage clinical studies at up to four sites to gather data for submission to Taiwan government regulatory agencies for approval.  Any regulatory filings will be in the name of Delcath Systems, Inc.  For the clinical studies, Chi-Fu will purchase, at a discount, Delcath PHP Systems to treat up to 200 patients with hepatic cancer.  Any additional systems required will be sold at a confidential distributor price.  It is intended that at least two of the clinical study sites will become reference sites when the studies are completed. 

Under the terms of the agreement, Delcath is to receive $1 million in milestone payments, comprised of $300,000 upon execution of the agreement and the balance upon receipt of the CE Mark and upon receipt of FDA approval. In addition Chi-Fu will be contractually committed to purchase a minimum number of systems annually during the term of the agreement, commencing when commercial sales begin in Taiwan. The term of th
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Lukes Cancer Center
4. Delcath Adds Dr. Pamela R. Contag to Its Board of Directors
5. Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
7. Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial
8. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
9. Delcath Systems, Inc. Completes Phase III Study Enrollment
10. Delcath Systems Begins Data Analysis of Phase III Trial
11. Delcath Systems, Inc. to Present at the 12th Annual Needham Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2015 Roche,s Bloodhound technology is on ... in hematology testing, according to Kalorama Information.  The ... of its Bloodhound digital cell imaging technology –as ... hematology analyzer – is notable as a ... current leader CellaVision, but also compete more broadly ...
(Date:7/2/2015)... , June 26, 2015 Research ... "Vitamin D Market by Analog, Application, End-User & by ... to their offering. This market is projected to ... vitamin D in different applications and rising opportunities in countries ... , Italy , and ...
(Date:7/2/2015)... --  EVO Aesthetic Center and Wellness Spa prides ... in Lakeway, Texas and will ... Duality laser. The medical spa is focused on helping ... laser procedures. Their addition of the Astanza Duality will ... their tattoo regret. "The large number of ...
Breaking Medicine Technology:Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3EVO Offers Advanced Laser Tattoo Removal With Astanza Duality In Lakeway, TX 2
... Technologies (OTC Bulletin Board: MCLN ), ... treatment and disposal of medical waste and the ... announced it has partnered with Triumvirate Environmental, a ... engineering and remediation. This agreement will enable Triumvirate ...
... Sequenom, Inc. (NASDAQ: SQNM ), a life sciences company ... results for the third quarter of 2011 after closing of the ... conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and ... the same day at 5:00pm ET (2:00pm PT) and will be ...
Cached Medicine Technology:MedClean Technologies Partners With Triumvirate Environmental 2MedClean Technologies Partners With Triumvirate Environmental 3Sequenom, Inc. Announces Date of Third Quarter 2011 Financial Results and Conference Call 2
(Date:7/3/2015)... ... 2015 , ... Scientists at several top US cancer centers believe they now ... Click here to read the complete story , just posted on the Surviving ... Medical Center, and New York University exposed mice with a mutation on the tumor ...
(Date:7/3/2015)... ... 03, 2015 , ... B. E. Smith, the only full-service ... a national chief nursing officer recruitment for Jane Phillips Medical Center ... industry, B. E. Smith has recently placed more than 1,000 healthcare executives into ...
(Date:7/3/2015)... ... July 03, 2015 , ... Talcum powder attorneys representing ... their existing Talcum Powder Cancer Lawsuit Center website. Just as the previous version did, ... news , offering timely lawsuit updates and ovarian cancer warning information. The site is ...
(Date:7/3/2015)... ... ... " Selfie on a Stick ” was featured on NewsWatch as part of ... consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the review ... Almost every smartphone has an incredibly powerful camera built into it. And when someone ...
(Date:7/3/2015)... ... 03, 2015 , ... The Celebrity Dresses is currently running a promotion through ... celebrities will have the opportunity to get 10% discount on orders that are over ... not have to use coupon codes or remember redemption codes. , There is ...
Breaking Medicine News(10 mins):Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2
... Medical Corporation,(CRM:TSX-V) announced today for the year ended ... its Centers for Colorectal Health compared to,1,699 patient ... Commenting on this achievement, Edward Wright, CEO of ... strong demand for the CRH,O,Regan hemorrhoid banding technology ...
... LENEXA, Kan., Feb. 5 Mediware Information,Systems, Inc. (Nasdaq: ... blood and medication management, reported total revenue for the ... $11,262,000 in the,comparable quarter in fiscal year 2007. Net ... four cents per fully diluted share, compared to net,income ...
... Trade Center had sleeplessness, other problems, study shows , , ... to the World Trade Center terrorist attacks boosted behavioral ... by researchers at the Mount Sinai School of Medicine ... 4 years of age who lived in or attended ...
... New position created to support growth at MDS ... Nordion, a leading provider,of medical isotopes and radiopharmaceuticals, ... position of Senior Vice-President Innovation.,Dr. Covitz will lead ... strategies and identifying new complimentary business,opportunities to better ...
... Access to ... Treatment, NEW YORK, ... finding a cure for breast cancer, the Avon,Foundation will bring together nearly ... Breast Cancer Forum, held February 4-6,in Houston, TX. This year,s Forum, titled ...
... Inc. (Nasdaq:,FVRL), a biopharmaceutical company developing patient-specific, active,immunotherapies ... it will,host a conference call and live webcast ... 2008 to discuss the Company,s fourth quarter and ... be issued before the U.S.,stock markets open that ...
Cached Medicine News:Health News:CRH Medical Corporation announces substantial increase in patient visits 2Health News:Mediware Reports Second Quarter Fiscal 2008 Results 2Health News:Mediware Reports Second Quarter Fiscal 2008 Results 3Health News:Mediware Reports Second Quarter Fiscal 2008 Results 4Health News:9/11 Exposure Linked to Behavior Trouble in Kids 2Health News:Dr. Peter Covitz Joins MDS Nordion as Senior Vice-President Innovation 2Health News:Avon Foundation Brings Together Breast Cancer Experts in Houston to Report Significant New Data 2Health News:Avon Foundation Brings Together Breast Cancer Experts in Houston to Report Significant New Data 3Health News:Favrille to Host Conference Call and Live Webcast to Discuss Fourth Quarter and Year End 2007 Financial Results on February 19, 2008 2
The rubber, whistle tip catheter with thumb valve has two side eyes to help minimize trauma....
Extra Long Gentle Vactrol® Connector., ,Indications For Usage: ,Removal of secretions from respiratory tract....
Gentle-Flo® Vactrol® Connector., ,Indications For Usage: ,Removal of secretions from respiratory tract....
D-Line Coude' Suction Catheter., ,Indications For Usage: , Removal of secretions from respiratory tract , For ease and greater assurance of entering and suctioning the left bronchus ...
Medicine Products: